| Literature DB >> 27328659 |
Steven Kho1, Jutta Marfurt2, Irene Handayuni2, Zuleima Pava2, Rintis Noviyanti3, Andreas Kusuma3, Kim A Piera2, Faustina H Burdam4, Enny Kenangalem4,5, Daniel A Lampah4, Christian R Engwerda6, Jeanne R Poespoprodjo4,5,7, Ric N Price2,8, Nicholas M Anstey2, Gabriela Minigo2, Tonia Woodberry2.
Abstract
BACKGROUND: Plasmodium falciparum and Plasmodium vivax infections compromise dendritic cell (DC) function and expand regulatory T (Treg) cells in both clinical disease (malaria) and experimental human sub-microscopic infection. Conversely, in asymptomatic microscopy-positive (patent) P. falciparum or P. vivax infection in endemic areas, blood DC increase or retain HLA-DR expression and Treg cells exhibit reduced activation, suggesting that DC and Treg cells contribute to the control of patent asymptomatic infection. The effect of sub-microscopic (sub-patent) asymptomatic Plasmodium infection on DC and Treg cells in malaria-endemic area residents remains unclear.Entities:
Keywords: Adults; Asymptomatic; Clinical immunity; Dendritic cell; Falciparum; Human; Malaria; Regulatory T cell; Sub-microscopic; Vivax
Mesh:
Year: 2016 PMID: 27328659 PMCID: PMC4915178 DOI: 10.1186/s12936-016-1382-7
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Study participants
| Characteristics | Values for indicated group [median (IQR)] or individual values | ||||||
|---|---|---|---|---|---|---|---|
| Control | Asymptomatic | Acute uncomplicated | |||||
| Sub-microscopic | Sub-microscopic | Patent | Patent | Malaria | Malaria | ||
|
|
|
|
|
|
| ||
| No. of subjects | |||||||
| Total | 83 | 19 | 15 | 17 | 19 | 6 | 8 |
| Female/male | 46/37 | 10/9 | 8/7 | 12/5 | 14/5 | 4/2 | 5/3 |
| Papuan/non-Papuan | 29/54 | 9/10 | 9/6 | 7/10 | 14/5 | 6/0 | 6/2 |
| Age (years) | 30 (25–37) | 31 (26–36) | 28 (21–31) | 28 (24–36) | 32 (30–36) | 21 (20–24)* | 27 (23–36) |
| Time resident in area (years) | 12 (5–20) | 10 (6–18) | 9 (5–25) | 10 (5–22) | 10 (2–15) | NA | NA |
| No. of parasites/µl | ND | ND | ND | 294 (82–2065) | 210 (89–696) | 24,725 (10,734–57,274)# | 58,341 (10,778–89,678)# |
| Lymphocyte count (109/l) | 2.5 (2.2–3.1) | 2.2 (1.5–2.6)a | 2.6 (2.2–3.7) | 2.5 (1.7–2.8) | 2.5 (1.8–3.7) | 1.4 (0.7–1.6)** | 1.0 (0.7–1.2)*** |
| Monocyte count (109/l) | 0.5 (0.4–0.6) | 0.4 (0.3–0.7) | 0.6 (0.4–0.7) | 0.6 (0.5–0.7)a | 0.5 (0.3–0.8) | 0.7 (0.6–0.7)* | 0.9 (0.4–1.4)a |
IQR interquartile range, ND no parasite detected by microscopy, NA data not available
Significantly different to control, Kruskal–Wallis test with Dunn’s multiple comparisons
* P < 0.05
** P < 0.005
*** P < 0.0005
#Significantly different to species-matched patent infection, Kruskal–Wallis test with Dunn’s multiple comparisons (P < 0.0005)
aSignificantly different to control, Mann–Whitney U test (P < 0.05)
Fig. 1HLA-DR MFI of total DC was determined in adult controls (n = 36), asymptomatic sub-microscopic P. falciparum (Pf) infection (n = 4), asymptomatic sub-microscopic P. vivax (Pv) infection (n = 7), asymptomatic patent P. falciparum infection (n = 16), asymptomatic patent P. vivax infection (n = 19), uncomplicated (UM) P. falciparum-infected adults (n = 6), and uncomplicated P. vivax-infected adults (n = 8). Graphs show median with interquartile range. Kruskal–Wallis test with Dunn’s multiple comparisons test was used to compare between groups (*significantly different to control). Data were obtained by analysis of fresh whole blood using 4-colour flow cytometry panels
Fig. 2Absolute number of a CD303+ plasmacytoid DC (pDC), b CD1c+ myeloid DC (mDC) and c CD141+ mDC in peripheral blood of controls (a n = 31, b n = 35 and c n = 25), asymptomatic sub-microscopic P. falciparum (Pf) infection (a n = 6, b n = 6 and c n = 4), asymptomatic sub-microscopic P. vivax (Pv) infection (a n = 8, b n = 8 and c n = 8), asymptomatic patent P. falciparum infection (a n = 14, b n = 17 and c n = 11), asymptomatic patent P. vivax infection (a n = 17, b n = 19 and c n = 16), and adults with uncomplicated malaria (UM) (a n = 4, b n = 8 and c n = 7). Graphs show median with interquartile range. #Kruskal–Wallis test with Dunn’s multiple comparisons test or *Mann–Whitney U test was used to compare between groups (*# significantly different to controls). Data were obtained by analysis of fresh whole blood using 4-colour flow cytometry panels
T cell data
| Parameter | Values for indicated group [median (IQR)] or individual values | ||||||
|---|---|---|---|---|---|---|---|
| Control | Asymptomatic | Acute uncomplicated | |||||
| Sub-microscopic | Sub-microscopic | Patent | Patent | Malaria | Malaria | ||
|
|
|
|
|
|
| ||
| No. of subjects | 70 | 17 | 12 | 12 | 18 | 6 | 8 |
| CD4 T cells/µl blood | 752 (611–914) | 570 (478–699)a | 733 (634–1165) | 836 (539–1041) | 773 (588–941) | 201 (117–351)** | 243 (170–321)*** |
| CD25+ CD127low CD4+ Treg cells/µl blood | 42 (33–53) | 36 (28–46) | 44 (40–59) | 41 (33–66) | 41 (30–54) | 14 (11–23)** | 16 (11–21)*** |
| % of Treg cells in CD4 T cells | 5.4 (4.6–6.2) | 6.1 (5.2–7.2) | 6.0 (4.1–6.9) | 6.3 (5.4–7.1) | 5.3 (4.4–6.5) | 6.9 (5.7–9.7) | 6.3 (5.6–7.4) |
| CD45RA− CD25high aTreg/µl blood | 8.0 (6.1–11.2) | 7.7 (5.9–10.2) | 8.2 (6.6–12.9) | 7.1 (2.8–9.9) | 6.0 (5.3–7.3)a | 3.9 (2.6–5.0)* | 4.3 (3.3–7.4)a |
| % of aTreg in total Treg cells | 20.7 (16.2–25.8) | 23.5 (17.9–28.0) | 19.8 (15.3–22.9) | 11.9 (8.6–16.4)** | 14.8 (13.0–18.1)a | 25.2 (20.1–33.8) | 29.2 (26.3–44.4)* |
| CD45RA+ CD25+ rTreg/µl blood | 12.3 (6.6–19.3) | 8.9 (6.8–13.9) | 14.0 (7.6–20.0) | 11.7 (9.3–19.3) | 10.0 (7.2–17.8) | 4.4 (3.1–6.0)* | 2.9 (1.7–4.1)*** |
| % of rTreg in total Treg cells | 31.7 (20.5–36.9) | 29.3 (21.1–35.2) | 27.7 (21.1–35.5) | 30.8 (22.3–36.2) | 28.6 (23.4–38.4) | 30.2 (19.1–33.4) | 19.4 (14.2–20.5)* |
| rTreg/aTreg ratio | 1.3 (0.9–1.9) | 1.0 (0.8–2.0) | 1.2 (0.9–2.5) | 2.3 (1.4–3.7)* | 1.8 (1.3–2.7)a | 1.1 (0.8–1.5) | 0.7 (0.4–0.9)** |
IQR interquartile range
Significantly different to control, Kruskal–Wallis test with Dunn’s multiple comparisons
* P < 0.05
** P < 0.005
*** P < 0.0005
aSignificantly different to control, Mann–Whitney U test (P < 0.05)